When the expression of those nine miRNAs was plotted as function of breast cancer molecular subtype, similar trends of miRNA expression were overall seen, whereas the expression was slightly higher in the HER2 and TN compared to the luminal cancer subtype. The gene discussed is ERBB2; the disease is breast carcinoma.